Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Foghorn Therapeutics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 79 | +8 |
| Shares | 39.4M | 1.55M | 40.0M | +2.10M (+5.5%) |
| Value | $226.9M | $8.89M | $372.4M | +$154.4M (+70.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,811,302 | $16.9M | 0.00% |
| Siren, L.L.C. | 720,720 | $6.71M | 0.34% |
| Trexquant Investment LP | 60,604 | $564.2K | 0.01% |
| Susquehanna International Group, LLP | 39,591 | $368.6K | 0.00% |
| Qube Research & Technologies Ltd | 20,549 | $191.3K | 0.00% |
| State of Wisconsin Investment Board | 16,944 | $157.7K | 0.00% |
| Sherbrooke Park Advisers LLC | 12,776 | $118.9K | 0.03% |
| XTX Topco Ltd | 10,900 | $101.5K | 0.01% |
| SG Americas Securities, LLC | 10,652 | $99.0K | 0.00% |
| Zacks Investment Management | 10,300 | $95.9K | 0.00% |
| Russell Investments Group, Ltd. | 1,477 | $13.8K | 0.00% |
| Catalyst Funds Management Pty Ltd | 1,000 | $9.31K | 0.00% |
| Sterling Capital Management LLC | 48 | $447 | 0.00% |
| Capital Performance Advisors LLP | 14 | $130 | 0.00% |
Sold out (6)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 720,720 | $4.14M |
| Driehaus Capital Management LLC | 568,470 | $3.27M |
| Perceptive Advisors LLC | 544,000 | $3.13M |
| Colony Group, LLC | 215,690 | $1.29M |
| Capital Analysts, LLC | 547 | $3.00K |
| VisionPoint Advisory Group, LLC | 210 | $1.21K |
Not filed for Q3 2024 yet (1)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,546,069 | $8.89M |